Belvedere Trading’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	–	–	240
2023 Q3	–	Sell	-1,758	Closed	-$82.1K	–	164
2023 Q2	$82.1K	Buy	+1,758	New	+$82.1K	﹤0.01%	112
2022 Q4	–	Sell	-18,394	Closed	-$808K	–	364
2022 Q3	$808K	Buy	+18,394	New	+$808K	0.03%	18